Anti-Inflammatory and Immunomodulatory Properties of a Crude Polysaccharide Derived from Green Seaweed Halimeda tuna: Computational and Experimental Evidences

Mar Drugs. 2024 Feb 11;22(2):85. doi: 10.3390/md22020085.

Abstract

In this study, we investigated for the first time the anti-inflammatory and immunomodulatory properties of crude polysaccharide (PSHT) extracted from green marine algae Halimeda tuna. PSHT exhibited anti-oxidant activity in vitro through scavenging 1, 1-diphenyl-2-picryl hydroxyl free radical, reducing Fe3+/ferricyanide complex, and inhibiting nitric oxide. PSHT maintained the erythrocyte membrane integrity and prevented hemolysis. Our results also showed that PSHT exerted a significant anti-edematic effect in vivo by decreasing advanced oxidation protein products and malondialdehyde levels and increasing the superoxide dismutase and glutathione peroxidase activities in rat's paw model and erythrocytes. Interestingly, PSHT increased the viability of murine RAW264.7 macrophages and exerted an anti-inflammatory effect on lipopolysaccharide-stimulated cells by decreasing pro-inflammatory molecule levels, including nitric oxide, granulocyte-macrophage colony-stimulating factor (GM-CSF) and tumor necrosis factor-alpha (TNF-α). Our findings indicate that PSHT could be used as a potential immunomodulatory, anti-inflammatory, anti-hemolytic, and anti-oxidant agent. These results could be explained by the computational findings showing that polysaccharide building blocks bound both cyclooxygenase-2 (COX-2) and TNF-α with acceptable affinities.

Keywords: PSHT; RAW 264.7; anti-hemolytic; anti-inflammatory activity; anti-oxidant; computational analysis; crude polysaccharide; immunomodulatory; molecular interactions.

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / pharmacology
  • Antioxidants / pharmacology
  • Cell Line
  • Chlorophyta* / metabolism
  • Cyclooxygenase 2 / metabolism
  • Lipopolysaccharides / pharmacology
  • Mice
  • Nitric Oxide / metabolism
  • Nitric Oxide Synthase Type II / metabolism
  • Polysaccharides / pharmacology
  • Rats
  • Seaweed* / metabolism
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Antioxidants
  • Nitric Oxide
  • Tumor Necrosis Factor-alpha
  • Anti-Inflammatory Agents
  • Polysaccharides
  • Lipopolysaccharides
  • Cyclooxygenase 2
  • Nitric Oxide Synthase Type II

Grants and funding

This work was funded by the Tuniso-Moroccan project (code 20PRD16).